vs
Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $783.7M, roughly 1.3× Insulet Corporation). Insulet Corporation runs the higher net margin — 13.0% vs 5.5%, a 7.5% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 31.2%). Insulet Corporation produced more free cash flow last quarter ($48.2M vs $23.5M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 27.1%).
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
ECG vs PODD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $783.7M |
| Net Profit | $55.3M | $101.6M |
| Gross Margin | 11.6% | 72.6% |
| Operating Margin | 6.8% | 18.7% |
| Net Margin | 5.5% | 13.0% |
| Revenue YoY | 33.2% | 31.2% |
| Net Profit YoY | 60.4% | 0.9% |
| EPS (diluted) | $1.09 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $783.7M | ||
| Q3 25 | $986.8M | $706.3M | ||
| Q2 25 | $921.5M | $649.1M | ||
| Q1 25 | $826.6M | $569.0M | ||
| Q4 24 | $759.6M | $597.5M | ||
| Q3 24 | $761.0M | $543.9M | ||
| Q2 24 | $703.4M | $488.5M | ||
| Q1 24 | $625.7M | $441.7M |
| Q4 25 | $55.3M | $101.6M | ||
| Q3 25 | $57.0M | $87.6M | ||
| Q2 25 | $52.8M | $22.5M | ||
| Q1 25 | $36.7M | $35.4M | ||
| Q4 24 | $34.5M | $100.7M | ||
| Q3 24 | $41.8M | $77.5M | ||
| Q2 24 | $39.0M | $188.6M | ||
| Q1 24 | $28.2M | $51.5M |
| Q4 25 | 11.6% | 72.6% | ||
| Q3 25 | 12.6% | 72.2% | ||
| Q2 25 | 13.0% | 69.7% | ||
| Q1 25 | 11.2% | 71.9% | ||
| Q4 24 | 11.4% | 72.1% | ||
| Q3 24 | 11.8% | 69.3% | ||
| Q2 24 | 12.6% | 67.7% | ||
| Q1 24 | 11.9% | 69.5% |
| Q4 25 | 6.8% | 18.7% | ||
| Q3 25 | 7.3% | 16.7% | ||
| Q2 25 | 7.9% | 18.7% | ||
| Q1 25 | 6.2% | 15.6% | ||
| Q4 24 | 6.1% | 18.3% | ||
| Q3 24 | 7.1% | 16.2% | ||
| Q2 24 | 7.3% | 11.2% | ||
| Q1 24 | 6.2% | 12.9% |
| Q4 25 | 5.5% | 13.0% | ||
| Q3 25 | 5.8% | 12.4% | ||
| Q2 25 | 5.7% | 3.5% | ||
| Q1 25 | 4.4% | 6.2% | ||
| Q4 24 | 4.5% | 16.9% | ||
| Q3 24 | 5.5% | 14.2% | ||
| Q2 24 | 5.5% | 38.6% | ||
| Q1 24 | 4.5% | 11.7% |
| Q4 25 | $1.09 | $1.42 | ||
| Q3 25 | $1.11 | $1.24 | ||
| Q2 25 | $1.03 | $0.32 | ||
| Q1 25 | $0.72 | $0.50 | ||
| Q4 24 | $0.68 | $1.38 | ||
| Q3 24 | $0.82 | $1.08 | ||
| Q2 24 | $0.76 | $2.59 | ||
| Q1 24 | $0.55 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $281.5M | $930.8M |
| Stockholders' EquityBook value | $629.8M | $1.5B |
| Total Assets | $1.7B | $3.2B |
| Debt / EquityLower = less leverage | 0.45× | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $553.0K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $281.5M | $930.8M | ||
| Q3 25 | $285.1M | $934.9M | ||
| Q2 25 | $288.6M | $939.0M | ||
| Q1 25 | $292.1M | $1.6B | ||
| Q4 24 | $295.6M | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $629.8M | $1.5B | ||
| Q3 25 | $573.0M | $1.4B | ||
| Q2 25 | $514.4M | $1.5B | ||
| Q1 25 | $460.2M | $1.3B | ||
| Q4 24 | $422.6M | $1.2B | ||
| Q3 24 | $453.3M | $1.1B | ||
| Q2 24 | $490.0M | $998.4M | ||
| Q1 24 | $464.3M | $790.7M |
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.6B | $3.0B | ||
| Q2 25 | $1.5B | $3.5B | ||
| Q1 25 | $1.4B | $3.5B | ||
| Q4 24 | $1.3B | $3.1B | ||
| Q3 24 | $1.3B | $3.0B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $2.6B |
| Q4 25 | 0.45× | 0.61× | ||
| Q3 25 | 0.50× | 0.68× | ||
| Q2 25 | 0.56× | 0.64× | ||
| Q1 25 | 0.63× | 1.21× | ||
| Q4 24 | 0.70× | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $48.2M | $183.3M |
| Free Cash FlowOCF − Capex | $23.5M | $48.2M |
| FCF MarginFCF / Revenue | 2.3% | 6.2% |
| Capex IntensityCapex / Revenue | 2.4% | 17.2% |
| Cash ConversionOCF / Net Profit | 0.87× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $90.0M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $48.2M | $183.3M | ||
| Q3 25 | $76.2M | $125.7M | ||
| Q2 25 | $25.3M | $196.5M | ||
| Q1 25 | $7.1M | $63.8M | ||
| Q4 24 | — | $147.7M | ||
| Q3 24 | $78.9M | $98.5M | ||
| Q2 24 | — | $96.5M | ||
| Q1 24 | $21.9M | $87.6M |
| Q4 25 | $23.5M | $48.2M | ||
| Q3 25 | $65.7M | $100.1M | ||
| Q2 25 | $12.3M | $177.9M | ||
| Q1 25 | $-11.4M | $51.5M | ||
| Q4 24 | — | $94.1M | ||
| Q3 24 | $60.9M | $71.8M | ||
| Q2 24 | — | $74.0M | ||
| Q1 24 | $12.6M | $65.5M |
| Q4 25 | 2.3% | 6.2% | ||
| Q3 25 | 6.7% | 14.2% | ||
| Q2 25 | 1.3% | 27.4% | ||
| Q1 25 | -1.4% | 9.1% | ||
| Q4 24 | — | 15.7% | ||
| Q3 24 | 8.0% | 13.2% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | 2.0% | 14.8% |
| Q4 25 | 2.4% | 17.2% | ||
| Q3 25 | 1.1% | 3.6% | ||
| Q2 25 | 1.4% | 2.9% | ||
| Q1 25 | 2.2% | 2.2% | ||
| Q4 24 | — | 9.0% | ||
| Q3 24 | 2.4% | 4.9% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | 1.5% | 5.0% |
| Q4 25 | 0.87× | 1.80× | ||
| Q3 25 | 1.34× | 1.43× | ||
| Q2 25 | 0.48× | 8.73× | ||
| Q1 25 | 0.19× | 1.80× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | 1.89× | 1.27× | ||
| Q2 24 | — | 0.51× | ||
| Q1 24 | 0.77× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECG
| Commercial | $594.5M | 59% |
| Utility | $203.5M | 20% |
| Industrial | $82.8M | 8% |
| Institutional | $66.1M | 7% |
| Service And Other | $28.4M | 3% |
| Transportation | $24.2M | 2% |
| Renewables | $19.8M | 2% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
